The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect - PubMed (original) (raw)
Review
. 2011 Mar 18;63(3):136-51.
doi: 10.1016/j.addr.2010.04.009. Epub 2010 May 2.
Affiliations
- PMID: 20441782
- DOI: 10.1016/j.addr.2010.04.009
Review
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
Jun Fang et al. Adv Drug Deliv Rev. 2011.
Abstract
The enhanced permeability and retention (EPR) effect is a unique phenomenon of solid tumors related to their anatomical and pathophysiological differences from normal tissues. For example, angiogenesis leads to high vascular density in solid tumors, large gaps exist between endothelial cells in tumor blood vessels, and tumor tissues show selective extravasation and retention of macromolecular drugs. This EPR effect served as a basis for development of macromolecular anticancer therapy. We demonstrated methods to enhance this effect artificially in clinical settings. Of great importance was increasing systolic blood pressure via slow angiotensin II infusion. Another strategy involved utilization of NO-releasing agents such as topical nitroglycerin, which releases nitrite. Nitrite is converted to NO more selectively in the tumor tissues, which leads to a significantly increased EPR effect and enhanced antitumor drug effects as well. This review discusses molecular mechanisms of factors related to the EPR effect, the unique anatomy of tumor vessels, limitations and techniques to avoid such limitations, augmenting tumor drug delivery, and experimental and clinical findings.
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
- Tumor delivery of macromolecular drugs based on the EPR effect.
Torchilin V. Torchilin V. Adv Drug Deliv Rev. 2011 Mar 18;63(3):131-5. doi: 10.1016/j.addr.2010.03.011. Epub 2010 Mar 18. Adv Drug Deliv Rev. 2011. PMID: 20304019 Review. - Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls.
Nakamura H, Fang J, Maeda H. Nakamura H, et al. Expert Opin Drug Deliv. 2015 Jan;12(1):53-64. doi: 10.1517/17425247.2014.955011. Epub 2014 Nov 26. Expert Opin Drug Deliv. 2015. PMID: 25425260 Review. - Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects.
Maruyama K. Maruyama K. Adv Drug Deliv Rev. 2011 Mar 18;63(3):161-9. doi: 10.1016/j.addr.2010.09.003. Epub 2010 Oct 28. Adv Drug Deliv Rev. 2011. PMID: 20869415 Review. - The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo.
Maeda H, Nakamura H, Fang J. Maeda H, et al. Adv Drug Deliv Rev. 2013 Jan;65(1):71-9. doi: 10.1016/j.addr.2012.10.002. Epub 2012 Oct 23. Adv Drug Deliv Rev. 2013. PMID: 23088862 Review. - Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting.
Maeda H. Maeda H. Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(3):53-71. doi: 10.2183/pjab.88.53. Proc Jpn Acad Ser B Phys Biol Sci. 2012. PMID: 22450535 Free PMC article. Review.
Cited by
- Synergistic Potential of Nanomedicine in Prostate Cancer Immunotherapy: Breakthroughs and Prospects.
Jiang Y, Wang C, Zu C, Rong X, Yu Q, Jiang J. Jiang Y, et al. Int J Nanomedicine. 2024 Oct 2;19:9459-9486. doi: 10.2147/IJN.S466396. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39371481 Free PMC article. Review. - Enhancing photothermal therapy of tumors with image-guided thermal control of gene-expressing bacteria.
Zeng F, Du M, Yang Y, Fang J, Wang Y, Goh M, Lin Y, Wang H, Yan F, Chen Z. Zeng F, et al. Theranostics. 2024 Sep 9;14(15):5945-5964. doi: 10.7150/thno.98257. eCollection 2024. Theranostics. 2024. PMID: 39346533 Free PMC article. - An iron-based metal-organic framework nanoplatform for enhanced ferroptosis and oridonin delivery as a comprehensive antitumor strategy.
Cai M, Fu T, Zhu R, Hu P, Kong J, Liao S, Du Y, Zhang Y, Qu C, Dong X, Yin X, Ni J. Cai M, et al. Acta Pharm Sin B. 2024 Sep;14(9):4073-4086. doi: 10.1016/j.apsb.2024.05.015. Epub 2024 May 24. Acta Pharm Sin B. 2024. PMID: 39309488 Free PMC article. - Strategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies.
Zhang Y, Tian J. Zhang Y, et al. ACS Omega. 2024 Aug 23;9(36):37459-37504. doi: 10.1021/acsomega.4c04573. eCollection 2024 Sep 10. ACS Omega. 2024. PMID: 39281920 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources